Qinyi Wang

Qinyi Wang is an accomplished professional with experience in the biotechnology and pharmaceutical sectors. Currently serving as an Associate at Charles River Associates since September 2022, Qinyi previously held positions such as Start Codon Venture Promoter at Start Codon and Consultant Intern at Inflection Point Biomedical Advisors, where significant insights into precision medicine and regulatory practices were gained. Academic credentials include a Master of Philosophy in Therapeutic Sciences from the University of Cambridge and a Bachelor's degree in Biological and Biomedical Sciences from Imperial College London. Qinyi's research contributions include work at Imperial College London's NHLI, focusing on B cell interactions in idiopathic pulmonary fibrosis, and as an Undergraduate Researcher at Peking University. Additionally, Qinyi has demonstrated leadership and project management skills through roles in consulting and education.